Bayer AG Sponsored ADR (BAYRY)
OTC
Closed
Aug 24, 2026
Day's Range
13.9852 wk Range
7.48Overview - BAYRY - Bayer AG Sponsored ADR
Key Statistics
Valuation
Enterprise Value
103.58B
P/E (Trailing)
‪28.38‬
P/E (Forward)
‪10.29‬
PEG Ratio
‪-0.13‬
Price / Sales (TTM)
‪1.21‬
Price / Book
‪1.59‬
EV / EBITDA
‪8.75‬
Profitability
Gross Margin
‪58.24%‬
Profit Margin
‪-3.83%‬
Operating Margin
‪9.18%‬
Return on Assets
‪3.18%‬
Return on Equity
‪-5.69%‬
Ownership
Shares Outstanding
982.42M
Float
3.92B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.34%‬
Price stats
Beta
‪0.83‬
50-Day Avg
‪13.31‬
200-Day Avg
‪11.61‬
Dividends
Payout Ratio
‪161.46%‬
Frequency
Annual
Analyst Consensus
4 analysts
Average price target
‪$ 15.97‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BAYRY - Bayer AG Sponsored ADR
Peers - BAYRY - Bayer AG Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
Profile Summary - BAYRY - Bayer AG Sponsored ADR
About
Bayer AG Sponsored ADR represents Bayer AG, a leading multinational life sciences company based in Germany, in the US stock market through American Depositary Receipts (ADRs). This financial asset allows US investors to gain exposure to Bayer's wide-ranging operations, which encompass pharmaceuticals, consumer health…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
